Biopharma News

Jul 18, 2014
By BioPharm International Editors
After rejecting several bids, Shire has agreed to a merger with AbbVie valued at almost $55 billion.
Jul 18, 2014
By BioPharm International Editors
CPhI 2014 panel additions to provide global insights from the contract services sector.
Jul 09, 2014
By BioPharm International Editors
FDA grants breakthrough therapy designation to Novartis chimeric antigen receptor therapy.
Jul 02, 2014
By BioPharm International Editors
Genentech's $1.7 billion acquisition of Seargon Pharmaceutical includes portfolio of investigational next-generation oral selective estrogen receptor degraders.
Jul 02, 2014
By BioPharm International Editors
PlantForm and PharmaPraxis announce plans to develop six biopharmaceutical targets for the Brazilian market.
Jul 01, 2014
By BioPharm International Editors
Bristol-Myers Squibb issues a voluntary US recall of Coumadin (warfarin sodium) for injection due to presence of particulate matter.
Jul 01, 2014
By BioPharm International Editors
Merck funds Bionomics with $20 million to progress therapies for cognitive impairment caused by central nervous system disorders
Jul 01, 2014
By BioPharm International Editors
The collaboration will use Mersana Therapeutics Fleximer technology for antibody-drug conjugates.
Jun 29, 2014
By BioPharm International Editors
Cytovance Biologics completes GMP manufacture of ARMO BioSciences' lead product.
Jun 29, 2014
By BioPharm International Editors
GSK and Save the Children announce criteria for awards that recognize innovation in healthcare for the world"s poorest children.
native1_300x100
lorem ipsum